Preeclampsia
643
98
114
297
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
44 trials with published results (7%)
Research Maturity
297 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.7%
30 terminated out of 643 trials
90.8%
+4.3% vs benchmark
14%
91 trials in Phase 3/4
15%
44 of 297 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 297 completed trials
Clinical Trials (643)
Exercise Testing After Preeclampsia
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Mortality Outcome of Controlled Hypertension
Vagal Stimulation Therapy and Preeclampsia
Dietary Salicylates and Preeclampsia
Analysis of Biological Progression and Regression of HELLP Syndrome in Time
Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotension in Preeclamptic Parturients
Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
PROtecting Maternal Brains From Injury and Stroke
Placental Imaging Techniques
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
MATERNAL SERUM CADHERİN-6 AS A PREDİCTOR OF PREECLAMPSİA
Placental Biology in Health and Disease
Preeclampsia Ratio (sFlt-1/PlGF)
Usability Evaluation of Gen AI-based Nutrition Chatbot for Pregnant Women
CONNEQT Pulse Validation Study
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)